A Cost-Utility Model Comparing Azilect ® (Rasagiline) with Standard Care and Entacapone in the Treatment of Parkinsonian Patients with Motor Fluctuations under Levodopa in Finland

A Cost-Utility Model Comparing Azilect ® (Rasagiline) with Standard Care and Entacapone in the Treatment of Parkinsonian Patients with Motor Fluctuations under Levodopa in Finland

2005 ISPOR Europe

Hudry, J. | Rinne, J. O. | Keranen, T. | Eckert, L. | Francois, C. | Volume: , Issue: , Pages: ,
https://www.doi.org/10.1016/S1098-3015(10)67556-0